Hosted on MSN12h
Tracking down the genetic causes of lupus to personalize treatment
Few treatments exist today beyond powerful ... The most common form, systemic lupus erythematosus (SLE), for example, is characterized initially by skin rashes—in particular, a butterfly-shaped rash ...
Lupus Foundation of America17h
Race and Social Determinants of Health Influence Low Lupus Disease Activity in Children with Childhood-Onset Systemic Lupus Erythematosus
New study finds that Black children and those identifying with more than one race have higher disease activity and are less likely to achieve low lupus disease activity state compared to White ...
rheumatologyadvisor19h
Nomogram Predicts Lupus Nephritis With Interstitial Fibrosis
Lupus nephritis progression may be faster in patients with interstitial fibrosis/tubular atrophy (IFTA). Now a nomogram may predict it.
Nature Helped Me Heal After I Was Diagnosed With Lupus. I'm Never Giving That Up.
Kisha Jarrett was an active child growing up. After being diagnosed with lupus, she had to pull back. This is how nature ...
Artist who tackles lupus in her paintings seeks a kidney donor
Three different versions of Alexandria Wingate appear in a trio of purple paintings the Baltimorean started while a fine art ...
Omaha woman, who has suffered with lupus pain, finding relief after receiving novel therapy
An Omaha mom of twins is believed to be the first to receive a newer type of CAR-T cell therapy for lupus at the University of Nebraska Medical Center.
Patrika5d
Bipolar disorder: What is Lupus disease, which prevents women from becoming mothers?
Becoming a mother is a happy feeling, and only a mother can understand this feeling. But in today’s time, a woman often loses ...
Positive Phase III Results for Genentech’s Gazyva Show Superiority to Standard Therapy Alone in People With Lupus Nephritis
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from the Phase ...
New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement
AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...